http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2014372739-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32442a1761c50204a02025c8ed897f52
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2014-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47ac553ae26cc08c6c0de551fc726f6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dde2ebfe1c00f51ebcc4167c992527f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e312a552f80f48ff6844d135803240e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c7aca311d47ddb4cd831cd0bf284722
publicationDate 2016-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2014372739-A1
titleOfInvention Optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagus
abstract Disclosed is an optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagus. Said pharmaceutical formulation in the form of an orodispersible effervescent tablet is stable, easy to produce, and can be used without dissolving same in a liquid. It is not necessary to drink anything with the tablet as this would reduce the time that the budesonide solution remains in the affected regions of the esophagus. The effervescent tablet of the invention surprisingly resulted in an unexpectedly high rate of histological remission in patients with active eosinophilic esophagitis.
priorityDate 2013-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506142
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516893
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448120876
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449525668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8950
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452919128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423352616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23662352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51064083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281004

Total number of triples: 44.